Neil O'Neill Gilmore
5 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
The 3 newest of 5 trades
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell(10b5-1 plan) | $51K | Nov 11SEC filing | |
| Sell(10b5-1 plan) | $16K | Sep 3SEC filing | |
| Sell(10b5-1 plan) | $42K | Jun 3SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Neil O'Neill Gilmore's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 5 |
Alerts for Neil O'Neill Gilmore
Use this page
How to cite
Breakaway, Neil O'Neill Gilmore: CEO at Editas Medicine (EDIT), Nov 13, 2026, getbreakaway.com/insiders/neil-oneill-gilmore
Journalists: email support@getbreakaway.com for the data behind this page.